Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review

The public consultation process for the assessment of co-dependent technology chapter of the draft revised Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines closed on 11 April 2016. The submissions received will be considered for inclusion in the finalisation of the revised PBAC Guidelines.

Further information on the Review is available on the PBAC Guidelines Review page.